Your browser is no longer supported. Please, upgrade your browser.
GSK GlaxoSmithKline plc weekly Stock Chart
GSK [NYSE]
GlaxoSmithKline plc
Index- P/E18.33 EPS (ttm)2.25 Insider Own0.20% Shs Outstand2.50B Perf Week0.71%
Market Cap103.27B Forward P/E13.53 EPS next Y3.05 Insider Trans0.00% Shs Float2.44B Perf Month2.63%
Income5.61B PEG1.80 EPS next Q0.78 Inst Own11.50% Short Float0.26% Perf Quarter2.25%
Sales39.17B P/S2.64 EPS this Y42.70% Inst Trans-0.29% Short Ratio2.72 Perf Half Y0.19%
Book/sh1.80 P/B22.96 EPS next Y3.04% ROA7.30% Target Price45.33 Perf Year4.26%
Cash/sh2.08 P/C19.91 EPS next 5Y10.20% ROE107.60% 52W Range36.41 - 42.49 Perf YTD8.14%
Dividend1.86 P/FCF27.88 EPS past 5Y-7.40% ROI16.00% 52W High-1.87% Beta0.68
Dividend %4.50% Quick Ratio0.50 Sales past 5Y3.10% Gross Margin68.50% 52W Low14.52% ATR0.50
Employees95490 Current Ratio0.70 Sales Q/Q6.80% Oper. Margin20.10% RSI (14)56.07 Volatility0.82% 0.92%
OptionableYes Debt/Eq9.26 EPS Q/Q117.30% Profit Margin13.90% Rel Volume1.40 Prev Close41.32
ShortableYes LT Debt/Eq6.45 EarningsOct 23 BMO Payout55.10% Avg Volume2.30M Price41.69
Recom2.00 SMA200.77% SMA501.51% SMA2003.93% Volume2,176,704 Change0.91%
Sep-03-19Upgrade Societe Generale Sell → Buy
Sep-03-19Resumed Citigroup Neutral
Aug-13-19Resumed JP Morgan Neutral
Jun-17-19Resumed Morgan Stanley Underweight
Mar-08-19Downgrade Shore Capital Buy → Hold
Feb-22-19Downgrade UBS Buy → Neutral
Jan-14-19Downgrade Exane BNP Paribas Outperform → Neutral
Dec-11-18Resumed Jefferies Buy
Oct-09-18Initiated Guggenheim Neutral
Aug-30-18Downgrade Liberum Buy → Hold
Apr-04-18Upgrade Exane BNP Paribas Neutral → Outperform
Mar-22-18Upgrade Morgan Stanley Underweight → Equal-Weight
Feb-09-18Upgrade Kepler Reduce → Hold
Nov-06-17Downgrade Investec Buy → Hold
Oct-26-17Downgrade BofA/Merrill Buy → Neutral
Sep-08-17Downgrade Morgan Stanley Equal-Weight → Underweight
Jul-05-17Downgrade Citigroup Buy → Neutral
May-26-17Upgrade Berenberg Hold → Buy
Apr-05-17Upgrade Exane BNP Paribas Underperform → Neutral
Mar-09-17Initiated Liberum Buy
Sep-19-19 04:58PM  Microsoft nominates GSK CEO Walmsley to board Reuters
04:37PM  Microsoft adds GlaxoSmithKline CEO to board, among other changes MarketWatch
03:20AM  5 Undervalued Stocks to Buy InvestorPlace
Sep-18-19 05:37PM  GSK's over-the-counter nicotine oral spray gets FDA panel backing Reuters
05:11PM  UPDATE 1-GSK's over-the-counter nicotine oral spray gets FDA panel backing Reuters
04:32PM  FDA panel recommends GSK's over-the-counter nicotine oral spray Reuters
10:04AM  Roche's Gazyva Now a Breakthrough Therapy for Lupus Nephritis Zacks
Sep-16-19 09:16AM  Here's Why GlaxoSmithKline (LON:GSK) Can Manage Its Debt Responsibly Simply Wall St.
Sep-13-19 10:08AM  Glaxo's Asthma Drug Nucala Gets FDA Nod for Pediatric Use Zacks
09:46AM  Pharma Stock Roundup: Pipeline/Regulatory Updates From GSK, PFE & Others Zacks
Sep-12-19 03:48PM  Nucala is the first biologic approved in the US for six to 11-year-old children with severe eosinophilic asthma Business Wire
Sep-11-19 03:50PM  Leaner Pfizer Positioned to Boost R&D Output GuruFocus.com
03:33PM  Factbox: Purdue OxyContin settlement would rank among largest in pharma history Reuters
Sep-06-19 04:45PM  Generic Drug Stocks Latch Onto Buyout News Leading To 3-Day Rally Investor's Business Daily
11:57AM  Pfizer is a Top Drugmaker: Is it the Right Time to Buy It? Zacks
Sep-04-19 02:43PM  Trying to turn 'natural killers' against cancer, Peninsula drug maker raises $114 million American City Business Journals
Sep-03-19 11:47PM  3 International Stocks Worth Watching Motley Fool
Sep-02-19 07:51AM  Here's Why Glaxo (GSK) Steadily Stays Ahead of Its Industry Zacks
Aug-30-19 11:16AM  AstraZeneca's Lupus Drug Meets Primary Endpoint in Study Zacks
Aug-29-19 09:06AM  Forget Pfizer, Add These Big Drugmakers to Your Portfolio Zacks
Aug-28-19 02:28PM  Emergent's Vaccine Portfolio Aids Growth Amid Competition Zacks
02:15PM  Ionis (IONS) Out-licenses Hepatitis B Virus Program to Glaxo Zacks
12:20PM  Jim Cramer Weighs In On GlaxoSmithKline, Wynn Resorts And More Benzinga
10:21AM  AstraZeneca's Fasenra Gets Orphan Drug Status for New Disease Zacks
10:18AM  AstraZeneca respiratory business gets boost from 3-drug inhaler results Reuters
06:25AM  GlaxoSmithKline Could Be Close to a Major Upside Move TheStreet.com
Aug-26-19 10:59AM  The Zacks Analyst Blog Highlights: U.S. Bancorp, Duke Energy, Glaxo, Ross Stores and Xylem Zacks
Aug-25-19 08:42PM  PRESS DIGEST- Financial Times - Aug 26 Reuters
03:44AM  Do GlaxoSmithKline's (LON:GSK) Earnings Warrant Your Attention? Simply Wall St.
Aug-24-19 11:44PM  HMRC targets GSK contractors in UK tax crackdown Financial Times
Aug-23-19 01:43PM  Top Analyst Reports for U.S. Bancorp, Duke Energy & Glaxo Zacks
09:40AM  Pharma Stock Roundup: ABBV's Rinvoq Gets FDA Nod, BAYRY to Sell Animal Health Unit Zacks
03:42AM  UPDATE 2-GSK builds oncology pipeline as drug shown to help myeloma patients Reuters
Aug-22-19 10:07AM  Glaxo Submits First Regulatory Application for Daprodustat Zacks
08:19AM  GSK's long acting HIV injection gets boost from study Reuters
03:28AM  UPDATE 2-GSK's long acting HIV injection gets boost from study Reuters
02:40AM  GSK new HIV two-drug injection meets main goal in late-stage study Reuters
Aug-19-19 12:42PM  3 Large-Cap Stocks With High Dividend Yields GuruFocus.com
Aug-18-19 07:28AM  Better Buy: Eli Lilly vs. GlaxoSmithKline Motley Fool
Aug-14-19 01:47PM  Ionis Pharmaceuticals Looks to Partners to Pay the Bills Motley Fool
01:00AM  Germany's Stada is "very selective" on acquisitions, CEO says Reuters
Aug-13-19 10:15AM  Should Value Investors Consider GlaxoSmithKline (GSK) Stock? Zacks
07:27AM  GSK's new pharma president carries Merck, Pfizer experience American City Business Journals
Aug-10-19 07:56PM  AnaptysBio Prepares for a Potential Gear Shift Motley Fool
Aug-09-19 11:09AM  Agenus (AGEN) Q2 Earnings Miss Estimates, Revenues Beat Zacks
Aug-08-19 01:15AM  Merck KGaA's Q2 profit bolstered by drug milestone payments Reuters
Aug-06-19 05:26PM  Kahn Brothers' Top 6 Buys in the 2nd Quarter GuruFocus.com
Aug-05-19 02:29PM  Local companies impacted by trade war-fueled stock market decline American City Business Journals
01:00AM  It Might Be Better To Avoid GlaxoSmithKline plc's (LON:GSK) Upcoming 1.1% Dividend Simply Wall St.
Aug-03-19 08:54AM  Edited Transcript of GSK.L earnings conference call or presentation 24-Jul-19 1:00pm GMT Thomson Reuters StreetEvents
Aug-02-19 10:52AM  Emergent (EBS) Earnings Miss in Q2, Revenues Beat Estimates Zacks
09:54AM  Pharma Stock Roundup: PFE, MRK, LLY Q2 Earnings, Upjohn-MYL Merger Zacks
Aug-01-19 03:37PM  Theravance (TBPH) Q2 Loss Narrower, Revenues Beat Estimates Zacks
11:17AM  GSK, Pfizer complete deal to combine consumer health brands American City Business Journals
07:18AM  The Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings Benzinga
Jul-31-19 09:55AM  Gilead (GILD) Q2 Earnings & Sales Beat, Sales Guidance Raised Zacks
Jul-29-19 03:29PM  Mylan (MYL) Beats on Q2 Earnings, Inks Deal with Pfizer Zacks
01:17PM  Pharmacia Corporation (Old Monsanto) -- Moody's reviews Pfizer's A1 rating for downgrade; affirms P-1 rating Moody's
12:17PM  Top 5 Dividend Stocks in the FTSE for 2018 Investopedia
11:40AM  Pfizer (PFE) Beats on Q2 Earnings, to Merge Upjohn With Mylan Zacks
09:27AM  3 Healthcare Stocks With Rising Expectations Motley Fool
07:24AM  Pfizer-Mylan Generic Giant Solves Two Problems With One Deal Bloomberg
Jul-26-19 08:39AM  Pharma Stock Roundup: GSK, BMY Q2 Earnings, FDA Nod to LLY's Hypoglycemia Treatment Zacks
Jul-25-19 10:01PM  Best of Lex: your weekly round-up Financial Times
09:59AM  Glaxo (GSK) Beats on Q2 Earnings, Shingrix Sales Strong Zacks
03:56AM  Astra, Roche Join Rivals in Boosting Forecasts as New Drugs Prosper Bloomberg
Jul-24-19 04:23PM  Why This Biotech Stock Is Cannibalizing Itself To Analyst's Applause Investor's Business Daily
01:54PM  What to Expect from Sanofi's (SNY) Q2 Earnings (Revised) Zacks
12:13PM  What to Expect from Sanofi's (SNY) Q2 Earnings Zacks
11:52AM  Why This Biotech Stock Is Cannibalizing Itself To Analyst's Applause Investor's Business Daily
10:46AM  Companies to Watch: Boeing takes massive hit, Caterpillar misses, VF Corp raises guidance Yahoo Finance
10:14AM  Companies to Watch: Boeing takes massive hit, Caterpillar misses, VF Corp raises guidance Yahoo Finance Video
09:56AM  WRAPUP 1-GSK raises 2019 earnings expectations after standout quarter for Shingrix Reuters
07:37AM  Glaxo (GSK) Beats Earnings & Revenue Estimates in Q2 Zacks
07:34AM  GSK raises 2019 earnings expectations after standout quarter for Shingrix Reuters
07:27AM  REFILE-UPDATE 1-GSK predicts smaller fall in 2019 profit after standout quarter for Shingrix Reuters
07:13AM  GSK forecasts smaller hit to FY profit after second quarter beat Reuters
06:42AM  Drugmaker GSK ends chairman search with HSBC's Symonds Reuters
05:05AM  GlaxoSmithKline says Symonds will become chairman MarketWatch
04:24AM  GlaxoSmithKline Beats Q2 Profit Estimate, Sees Stronger 2019 Despite Advair Loss TheStreet.com
Jul-23-19 11:54PM  GSK: betting the pharm Financial Times
11:26PM  GSK market hopes boosted by two-drug HIV trial Financial Times
09:01AM  What Should Investors Know About GlaxoSmithKline plc's (LON:GSK) Future? Simply Wall St.
08:46AM  Should You Buy Glaxo (GSK) Ahead of Earnings? Zacks
Jul-22-19 10:06AM  Can Allergan (AGN) Keep the Earnings Streak Alive in Q2? Zacks
Jul-21-19 09:05PM  PRESS DIGEST- Financial Times - July 22 Reuters
Jul-20-19 12:07PM  8 More Big Pharma Events in 2019 You Don't Want to Miss Motley Fool
06:00AM  GSK sets out strategy to double drug discovery success Financial Times
02:54AM  Why GlaxoSmithKline plc (LON:GSK) Could Have A Place In Your Portfolio Simply Wall St.
Jul-19-19 09:53AM  Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, Pipeline/Regulatory Updates in Focus Zacks
Jul-18-19 11:11AM  Is a Beat in Store for Glaxo (GSK) This Earnings Season? Zacks
Jul-17-19 09:59AM  Swiss agree to extradite Chinese scientist to U.S. on theft charges Reuters
Jul-16-19 10:51AM  Glaxo's Zejula Meets Goal in First-Line Ovarian Cancer Study Zacks
Jul-15-19 02:46PM  Biotech investors Wellington, RA Capitals new funds top $700 million American City Business Journals
08:59AM  Gilead-Galapagos Ink $5.1B Deal for Additional Compounds Zacks
08:27AM  GSK drug helps ovarian cancer patients live longer in late-stage study Reuters
07:00AM  AI Drug Hunters Could Give Big Pharma a Run for Its Money Bloomberg
04:02AM  Ovarian cancer treatment boosts GSK Financial Times
02:52AM  UPDATE 2-GSK drug helps ovarian cancer patients live longer in late-stage study Reuters
Jul-14-19 09:10PM  PRESS DIGEST- Financial Times - July 15 Reuters
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories primarily under the Sensodyne, parodontax, Poligrip, Voltaren, Panadol, Otrivin, and Theraflu brand names. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, pods, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, and malted drinks and foods. It has collaboration agreements with 23andMe; Liquidia Technologies, Inc.; and SpringWorks Therapeutics, Inc., as well as a strategic alliance with Merck KGaA. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLCDirectorSep 10Buy45.00177,7777,999,9652,170,327Sep 12 04:18 PM
GLAXOSMITHKLINE PLCDirectorJul 01Buy15.00333,3334,999,9952,633,772Jul 02 04:13 PM
GLAXOSMITHKLINE PLCDirectorMay 28Buy14.00385,7145,399,9961,915,275May 30 05:47 PM
GLAXOSMITHKLINE PLCDirectorApr 22Buy18.00325,0005,850,0001,992,550Apr 24 07:28 PM